Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-12-09

Clinical Trial Update: Sipuleucel-T Manufacturing Demonstration Study [Phase 2]

View source ↗

Summary

Phase 2 sipuleucel-T manufacturing demonstration study for prostate cancer completed; results posted in December 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PROVENGE (sipuleucel-T)

Snippet

Sponsor: Dendreon | Conditions: Cancer of Prostate, Cancer of the Prostate | Phase 2 | Status: COMPLETED | Results posted: 2015-12-09